News, reviews and podcasts from annual scientific meetings and symposiums around the world.
ESMO 2021: Update on INVICTUS trial shows improved overall median survival in GIST patients using ripretinib
Results from the phase 3 INVICTUS clinical trial show that the drug ripretinib provides clinically…